EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Caracterización del cáncer de mama HER2 positivo en pacientes atendidas en un hospital de Managua: Una serie de casos

Alfredo Saavedra Dolmuz, Jairo Campos Valerio, Ivonne Dessireé Leytón Padilla, María Elena Saavedra Arce, Mónica Saavedra Flores

Revista de Ciencias de la Salud de la Universidad Americana · 2025

DOI: 10.62407/zeenc987 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista de Ciencias de la Salud de la Universidad Americana, 2025. Verfasst von Alfredo Saavedra Dolmuz und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To characterize HER2-positive breast cancer in patients treated at the Oncology unit of the Hospital Carlos Roberto Huembes between June 2016 and June 2022. Materials and Methods: Observational, descriptive, case series study, with a sample of 44 patients diagnosed with HER2 breast cancer. Information was obtained from clinical records and analyzed using IBM SPSS version 27 software.

Results

40.9% of the patients were between 51 and 60 years old, 97.7% were from urban areas, and 34.4% were overweight. Only 4.5% had a personal history of breast cancer, while 25% reported a family history. 63.6% of the cases corresponded to the Luminal B subtype, and only 34.6% were classified as pure HER2+. 34.1% were found in clinical stage IIA, and invasive ductal carcinoma predominated in 81.8% of the cases. Metastasis was not documented in 70.5%, with visceral metastases being the most common among those who presented with them. 100% of the patients underwent surgery, followed by biological therapy and chemotherapy. Currently, 40.9% are in treatment, 38.7% are under surveillance, and only 27.5% have died.

Conclusion

Historically, HER2+ breast cancer has been associated with unfavorable prognoses due to diagnoses at advanced stages. However, in this study, patients were diagnosed at early stages, which, along with therapies targeted against HER2, is related to a better therapeutic response and an increase in survival.

Zitieren

APA

Dolmuz, A. S., Valerio, J. C., Padilla, I. D. L., Arce, M. E. S., & Flores, M. S. (2025). Caracterización del cáncer de mama HER2 positivo en pacientes atendidas en un hospital de Managua: Una serie de casos. Revista de Ciencias de la Salud de la Universidad Americana. https://doi.org/10.62407/zeenc987

Vancouver

Dolmuz AS, Valerio JC, Padilla IDL, Arce MES, Flores MS. Caracterización del cáncer de mama HER2 positivo en pacientes atendidas en un hospital de Managua: Una serie de casos. Revista de Ciencias de la Salud de la Universidad Americana. 2025. doi:10.62407/zeenc987

BibTeX
@article{Dolmuz2025,
  author = {Dolmuz, Alfredo Saavedra and Valerio, Jairo Campos and Padilla, Ivonne Dessireé Leytón and Arce, María Elena Saavedra and Flores, Mónica Saavedra},
  title = {Caracterización del cáncer de mama HER2 positivo en pacientes atendidas en un hospital de Managua: Una serie de casos},
  journal = {Revista de Ciencias de la Salud de la Universidad Americana},
  year = {2025},
  doi = {10.62407/zeenc987}
}
Kostenlos starten →